Discontinuation report APO-SUCRALFATE - TAB 1G
| Report ID | 61033 |
| Drug Identification Number | 02125250 |
| Brand name | APO-SUCRALFATE - TAB 1G |
| Common or Proper name | SUCRALFATE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUCRALFATE |
| Strength(s) | 1G |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 BTL |
| ATC code | A02BX |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-09-14 |
| Remaining supply date | 2018-09-14 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-09-10 | English | Compare |
| v2 | 2018-09-10 | French | Compare |
| v3 | 2018-09-15 | English | Compare |
Showing 1 to 3 of 3